Uday Devgan, MD
Ophthalmology · Los Angeles, CANPI 1801831219
Payments from drug & device makers
What this record shows
This record is dominated by grants: $150,000 of the $189,251 with a category attached, or 79.3%. Harrow Eye, LLC accounts for 79.3% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2024 at $151,286 and has fallen 99.4% since, to $953 in 2025. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $1213.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harrow Eye, LLC$150K
- Novartis$22K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$8K
- Alcon$3K
- Sun Pharmaceutical Industries Inc.$1K
- Carl Zeiss Meditec USA, Inc.$935
- plus $4K from 18 others
What the payments were for
- Speaking & faculty fees$25,59514%
- Grants$150,00079%
- Travel & lodging$3,2352%
- Food & beverage$10,3655%
- Gifts$560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harrow Eye, LLC | 4 | $150,000 |
| Novartis | 44 | $22,392 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 16 | $8,335 |
| Alcon | 25 | $2,657 |
| Sun Pharmaceutical Industries Inc. | 14 | $1,252 |
| Carl Zeiss Meditec USA, Inc. | 8 | $935 |
| Bausch & Lomb Americas Inc. | 9 | $894 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $531 |
| AbbVie(2 entities) | 4 | $342 |
| Carl Zeiss Meditec, Inc. | 4 | $332 |
| Microsurgical Technology, Inc. | 1 | $265 |
| Tarsus Pharmaceuticals, Inc. | 2 | $250 |
| Rxsight Inc | 2 | $187 |
| Glaukos Corporation | 1 | $166 |
| Sight Sciences, Inc. | 2 | $160 |
| Ocular Therapeutix, Inc. | 1 | $128 |
| CSL Behring | 1 | $125 |
| Dompe US, Inc. | 3 | $102 |
| Eyevance Pharmaceuticals LLC | 3 | $63 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Shire North American Group Inc | 1 | $29 |
| Rayner Intraocular Lenses Limited | 1 | $28 |
| Quidel Corporation | 1 | $24 |
| NEW World Medical,inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IHEEZO$150,000
- STELLARIS PC$7,656
- CRYSTALENS$7,531
- AKREOS AO$7,531
- ENVISTA$7,531
- TRULIGN TORIC$7,531
- DUREZOL$2,450
- CEQUA$958
- BROMSITE$734
- XELPROS$734
- AcrySof$384
- enVista MX60 IOL$355
- AMVISC$355
- Clareon$286
- XIIDRA$284
- XDEMVY$250
- QUATERA 700$208
- RESCAN 700$206
- VUITY$184
- ARTEVO 800$177
How this compares
$189,251 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Los Angeles
- Andrew MoshfeghiLos Angeles$895K
- Barry SeibelLos Angeles$835K
- Nicole FramLos Angeles$551K
- Neda ShamieLos Angeles$547K
- David BoyerLos Angeles$406K
- David HamiltonLos Angeles$359K
- Arjan HuraLos Angeles$306K
- Firas RahhalLos Angeles$264K
- Kouros NourimahdaviLos Angeles$258K
- Daniel RootmanLos Angeles$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.